Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement
First insights from the EAS Familial Hypercholesterolaemia Collaboration Registry: FH is still underdiagnosed and undertreated
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
